PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
09-Sep-2022 Medidata Publishes Research Report About the Future of Clinical Trials Medidata
09-Sep-2022 HUTCHMED Highlights Phase III FRESCO-2 MRCT Data Summary of Fruquintinib in Refractory Metastatic Colorectal Cancer from the Upcoming ESMO 2022 Presentation HUTCHMED
09-Sep-2022 Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress Immunocore
09-Sep-2022 Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines PT Bio Farma (Persero)
08-Sep-2022 IgniteData joins strategic Vulcan HL7 FHIR Accelerator collaboration IgniteData
07-Sep-2022 mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022 mdgroup
07-Sep-2022 Global Big Data Analytics in healthcare market is expected to reach US$45.64 billion in 2026: Visiongain Reports Ltd Visiongain Reports Limited
07-Sep-2022 Anti-Infective Agents Market Will Grow at a CAGR of 4.3% by 2031: Visiongain Reports Ltd Visiongain Reports Limited
07-Sep-2022 mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022 mdgroup
06-Sep-2022 New Tezspire data at ERS International Congress 2022 continue to strengthen profile for a broad population of severe asthma patients AstraZeneca
06-Sep-2022 Next Generation Sequencing Market Worth US$30,424.3 Million by 2031: Visiongain Reports Ltd Visiongain Reports Limited
06-Sep-2022 Companion Diagnostics Market Worth US$16,056 million by 2031: Visiongain Reports Ltd Visiongain Reports Limited
06-Sep-2022 Immutep announces investigator-initiated Phase II trial evaluating LAG-3 candidate eftilagimod alpha (efti) in soft tissue sarcoma Immutep
06-Sep-2022 Enterome to present updates on EO2401, its first-in-class OncoMimics™ therapeutic cancer vaccine targeting solid tumors, at ESMO Congress 2022 Enterome
06-Sep-2022 Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs Avance Clinical
06-Sep-2022 Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma Sanofi
05-Sep-2022 Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC Novotech Health Holdings Pte Ltd
03-Sep-2022 APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report Novotech Health Holdings Pte Ltd
01-Sep-2022 Clinical trials legal service provider cements expansion plans with first US office CTA Focus
01-Sep-2022 JAMA Neurology Publishes Positive Pivotal Clinical Trial with Vamorolone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals